This is a competing renewal application for a multi-institutional Program Project Grant (PPG) that focuses on cognitive impairment due to small-vessel cerebrovascular disease (s-CVD). The long-term goals of this program Project are to 1) improve our understanding of the pathogenesis of subcortical ischemic vascular dementia (SIVD) and its interactions with Alzheimer's disease (AD), and 2) to develop and validate clinical and imaging markers that inform clinical diagnosis and prognosis. Previous findings from this Project have shown that both SIVD and AD are associated with changes in cerebral cortex, including atrophy, glucose hypometabolism, and loss of n-acetyl aspartate [NAA]. We hypothesize, however, that the mechanisms leading to these cortical and cognitive changes differ in these two disorders. Because s-CVD and Alzheimer disease frequently co-exist in persons over age 65 years, we propose to develop continuous, rather than binary, measures that describe the relative contributions of s-CVD and AD to cognitive impairment. Three Cores and four Projects are built around a prospective longitudinal study design and complementary multi-modal measures of brain structure and function. The Central Coordinating Core (CCC) recruits and follows over 500 subjects representing a spectrum of cognitive impairment attributed to either s-CVD or AD, as well as normal controls. The Imaging Core (Weiner) quantifies volumes of lacunes [L], white matter lesions [WML], cortical gray matter [cGM], and hippocampus [HV] over time. The Pathology Core (Vinters) determines the nature and severity of neurodegenerative, ischemic, and cerebrovascular pathology for each autopsy case. Project 1 (Reed) tests structural-functional-behavioral relationships associated with regional glucose hypometabolism (measured by FDG-PET) in the dorsolateral frontal vs. temporal-parietal lobes. Project 2 (Weiner) tests for differences in brain-metabolic-behavioral relationships in SIVD and AD, using N-acetylaspartate [NAA] and myoinositol from MRSI, as well as perfusion- and diffusion-tensor MR. Project 3 (Chui) seeks the pathological correlates of hippocampal and cortical atrophy, WML, and lacunes, using computerized co-registration of post-mortem brain with in vivo MRI. Project 5 (Mungas) uses multi-variate random effects analyses to model, over time, the neuropsychological and structural MRI correlates of dementia in s-CVD and AD. By integrating multidimensional data obtained using state-of the art methods, we propose to advance understanding of the pathogenesis of cognitive impairment associated with s-CVD and AD and to provide quantitative tools for diagnosis and prognosis.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG012435-11
Application #
6905495
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J3))
Program Officer
Molchan, Susan
Project Start
1994-09-30
Project End
2008-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
11
Fiscal Year
2005
Total Cost
$2,303,941
Indirect Cost
Name
University of Southern California
Department
Neurology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Seo, Sang Won; Ayakta, Nagehan; Grinberg, Lea T et al. (2017) Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage Clin 13:130-137
Lao, Yi; Nguyen, Binh; Tsao, Sinchai et al. (2017) A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile. Neuroimage Clin 14:298-307
Ramirez-Gomez, Liliana; Zheng, Ling; Reed, Bruce et al. (2017) Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort. Dement Geriatr Cogn Disord 44:1-11
Zheng, Ling; Vinters, Harry V; Mack, Wendy J et al. (2016) Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab 36:204-15
Durazzo, Timothy C; Korecka, Magdalena; Trojanowski, John Q et al. (2016) Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. J Alzheimers Dis 54:99-107
Villeneuve, Sylvia; Rabinovici, Gil D; Cohn-Sheehy, Brendan I et al. (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138:2020-33
Bron, Esther E; Smits, Marion; van der Flier, Wiesje M et al. (2015) Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge. Neuroimage 111:562-79
Vinters, Harry V (2015) Emerging concepts in Alzheimer's disease. Annu Rev Pathol 10:291-319

Showing the most recent 10 out of 208 publications